These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24299607)

  • 21. Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
    Tian Y; Zhang J; Zhao Y; Mao J; Zhu L; Gao R; Wang X; Zhu M; Ma L; Zhao M; Zheng W
    Trials; 2018 Oct; 19(1):577. PubMed ID: 30342551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial.
    Parker S; Zhang AL; Zhang CS; Goodman G; Wen Z; Lu C; Xue CC
    Trials; 2014 Dec; 15():495. PubMed ID: 25526951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of Wuling capsule, a single herbal formula, in Chinese subjects with insomnia: a multicenter, randomized, double-blind, placebo-controlled trial.
    Lin Y; Wang XY; Ye R; Hu WH; Sun SC; Jiao HJ; Song XH; Yuan ZZ; Zheng YY; Zheng GQ; He JC
    J Ethnopharmacol; 2013 Jan; 145(1):320-7. PubMed ID: 23178661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study.
    Yoo DH; Racewicz A; Brzezicki J; Yatsyshyn R; Arteaga ET; Baranauskaite A; Abud-Mendoza C; Navarra S; Kadinov V; Sariego IG; Hong SS; Lee SY; Park W
    Arthritis Res Ther; 2016 Apr; 18():82. PubMed ID: 27038608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of Qi-Wei-Qing-Yan aerosol in treatment of acute pharyngitis (lung-stomach excess-heat syndrome): study protocol for a randomized controlled trial.
    Jiang HL; She B; Liu W; Mao B; Zhang JY
    Trials; 2016 Feb; 17():99. PubMed ID: 26896352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of Sipjeondaebo-tang in Korean patients with cold hypersensitivity in the hands and feet: a protocol for a pilot, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
    Ko Y; Sun SH; Han IS; Go HY; Kim TH; Lee JM; Jang JB; Park KS; Song YK; Lee KY; Jeon CY; Ko SG
    Trials; 2019 Apr; 20(1):217. PubMed ID: 30987667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial.
    Luo Q; Zhou S; Li X; Chen Q; Lin W; Lu L; Li H; Chen C; Chen W; Li Y
    Trials; 2019 Jan; 20(1):66. PubMed ID: 30658660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study.
    Smolen JS; Kay J; Doyle M; Landewé R; Matteson EL; Gaylis N; Wollenhaupt J; Murphy FT; Xu S; Zhou Y; Hsia EC
    Arthritis Res Ther; 2015 Jan; 17(1):14. PubMed ID: 25627338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
    Nuki G; Bresnihan B; Bear MB; McCabe D;
    Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Efficacy and safety of Xinfeng capsule in the treatment of osteoarthritis: a multicenter, randomized, double-blinded, controlled trial".
    Liu J; Wang Y; Sun Y; Huang C; Chen X; Zhang W; He L; James Cheng-Chung W
    J Tradit Chin Med; 2020 Apr; 40(2):284-295. PubMed ID: 32242394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study.
    Genovese MC; Van den Bosch F; Roberson SA; Bojin S; Biagini IM; Ryan P; Sloan-Lancaster J
    Arthritis Rheum; 2010 Apr; 62(4):929-39. PubMed ID: 20131262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.
    Li B; Wang Y; Lu J; Liu J; Yuan Y; Yu Y; Wang P; Zhao X; Wang Z
    Trials; 2015 Dec; 16():561. PubMed ID: 26654631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial.
    Rigby W; Tony HP; Oelke K; Combe B; Laster A; von Muhlen CA; Fisheleva E; Martin C; Travers H; Dummer W
    Arthritis Rheum; 2012 Feb; 64(2):350-9. PubMed ID: 21905001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Xinyue capsules on patients with coronary heart disease after percutaneous coronary intervention: study protocol for a randomized controlled trial.
    Guo M; Zi MJ; Xi RX; Yang QN; Bai RN; Zhang YS; Wang YH; Wang PL; Shi DZ
    Trials; 2016 Aug; 17():412. PubMed ID: 27538952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study.
    Roman-Blas JA; Castañeda S; Cutolo M; Herrero-Beaumont G
    Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1588-93. PubMed ID: 20556817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of rheumatoid arthritis by xinfeng capsule: an efficacy observation].
    Huang CB; Liu J; Chen X; Wang Y; Zhang WD; Chen RL; Wang GZ; Fan HX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1599-602. PubMed ID: 24517052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of Gantong Granules in the treatment of common cold with wind-heat syndrome: study protocol for a randomized controlled trial.
    Min J; Li XQ; She B; Chen Y; Mao B
    Trials; 2015 May; 16():219. PubMed ID: 25986648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial.
    Wan Y; Yang J; Ma T; Wang W; Wang H; Sun W; Ye W; Yang L; Ren J; Kou Q
    Front Pharmacol; 2022; 13():945565. PubMed ID: 36299880
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of rheumatoid arthritis with roxithromycin: a randomized trial.
    Ogrendik M; Karagoz N
    Postgrad Med; 2011 Sep; 123(5):220-7. PubMed ID: 21904105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.